Loading insider details...
Latest Form 4 (Nov 12, 2026): Grant/Award of 1,560,599 MTRI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | InMed Pharmaceuticals Inc. (MTRI) | Grant/Award | 1,560,599 | n/a |
| Feb 12, 2026 | AVADEL PHARMACEUTICALS PLC (AVDL) | Disposition to Issuer | 211,105 | $4.43M |
| Mar 7, 2025 | AVADEL PHARMACEUTICALS PLC (AVDL) | Grant/Award | 52,000 | n/a |
| Dec 10, 2024 | AVADEL PHARMACEUTICALS PLC (AVDL) | Purchase | 9,598 | $95.8K |
| Mar 4, 2024 | AVADEL PHARMACEUTICALS PLC (AVDL) | Grant/Award | 600,000 | n/a |
| Aug 10, 2023 | AVADEL PHARMACEUTICALS PLC (AVDL) | Purchase | 10,000 | $132.0K |
| Jun 6, 2023 | AVADEL PHARMACEUTICALS PLC (AVDL) | Grant/Award | 350,000 | n/a |
| May 31, 2022 | AVADEL PHARMACEUTICALS PLC (AVDL) | Purchase | 50,000 | $102.5K |
| May 18, 2022 | Jaguar Health, Inc. (JAGX) | Exercise/Conversion | 12,133 | n/a |
| Mar 31, 2022 | Jaguar Health, Inc. (JAGX) | Grant/Award | 85,900 | n/a |